Investing Profile

Iain Dukes

InvestorVC
Venture Partner at OrbiMed
orbimed.comPhiladelphia, Pennsylvania
Photo of Iain Dukes, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
3
$18B
CompanyStageDateRound SizeTotal Raised
Mondego Bio
Series ASep 2025
ENYO Pharma
Series CJan 2024$43M
Series BJun 2018$47M
$90M
Co-investors: Carl Gordon (OrbiMed Advisors), Raphael Wisniewski (Andera Partners)
VP Scientific and Technology Licensing GSKPresent
President HotmailPresent
VP External R&D AmgenPresent
SVP Licensing & External Science MerckPresent
Chairman of the Board Iovance Biotherapeutics, Inc.Present
Board Member HotmailPresent
President Kartos Therapeutics, Inc.Present
Chairman of the Board HotmailPresent
President Kartos TherapeuticsPresent
Chairman of the Board KaNDY Therapeutics, Ltd.Present
Board Member ENYO PharmaPresent
President & CEO HotmailPresent
Venture Partner OrbiMedPresent
CEO HotmailPresent
CEO Theseus PharmaceuticalsPresent
CEO ViriomPresent
CEO Viriom IncPresent
University of Bath BSc Pharmacology
University of Leeds MSc Cardiovascular Studies
University of Oxford DPhil Physiology/Pharmacology
University of Oxford MA Jurisprudence (Law)